首页> 外国专利> Covalently bound to bile acids or sterols heparin, its use and pharmaceutical compositions containing them

Covalently bound to bile acids or sterols heparin, its use and pharmaceutical compositions containing them

机译:共价结合胆汁酸或固醇肝素,其用途和包含它们的药物组合物

摘要

Polysaccharides, which are widely used as anticoagulation drugs, especially heparin, are clinically administered only by intravenous or subcutaneous injection because of their strong hydrophilicity and high negative charge. Amphiphilic heparin derivatives were synthesized by conjugate to bile acids, sterols, and alkanoic acids, respectively. The hydrophobicity of the heparin derivatives depended on the feed mole ratio of heparin to hydrophobic agent. The heparin derivatives were slightly hydrophobic and exhibited good solubility in a water-acetone solvent, as well as water. The heparin derivatives have a high anticoagulant activity. These slightly hydrophobic heparin derivatives can be absorbed in gastric intestinal tract and can be used as oral dosage form. Also, the heparin derivatives can be used for the surface modification to prevent coagulation for medical devices such as extracorporeal devices and implanted devices.
机译:多糖,尤其是肝素,被广泛用作抗凝药物,由于其强亲水性和高负电荷,临床上只能通过静脉内或皮下注射给药。通过分别与胆汁酸,固醇和链烷酸缀合来合成两亲肝素衍生物。肝素衍生物的疏水性取决于肝素与疏水剂的进料摩尔比。肝素衍生物略微疏水并且在水-丙酮溶剂以及水中显示出良好的溶解性。肝素衍生物具有高抗凝活性。这些稍微疏水的肝素衍生物可以在胃肠道吸收,并且可以用作口服剂型。而且,肝素衍生物可用于表面修饰,以防止医疗器械如体外器械和植入器械的凝结。

著录项

  • 公开/公告号DE19981169B4

    专利类型

  • 公开/公告日2007-09-13

    原文格式PDF

  • 申请/专利权人 MEDIPLEX CORPORATION;

    申请/专利号DE1999181169

  • 发明设计人

    申请日1999-05-14

  • 分类号C08B37/10;A61L27/20;A61L29/16;A61L31/16;A61L33/10;

  • 国家 DE

  • 入库时间 2022-08-21 20:30:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号